Ocular Therapeutix (OCUL) Profit After Tax (2013 - 2026)

Ocular Therapeutix's Profit After Tax history runs 14 years deep, the most recent figure standing at -$88.6 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 38.34% year-over-year to -$88.6 million; the TTM figure through Mar 2026 stood at -$290.5 million (down 50.74% YoY), while the FY2025 annual figure was -$265.9 million, down 37.43% from the prior year.
• Profit After Tax was -$88.6 million for Q1 2026 at Ocular Therapeutix, down from -$64.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$516000.0 in Q3 2023 to a low of -$88.6 million in Q1 2026.
• Historically, Profit After Tax has averaged -$41.2 million across 5 years, with a median of -$36.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 97.87% in 2023, then plunged 6972.29% in 2024.
• A 5-year view of Profit After Tax shows it stood at -$15.5 million in 2022, then slumped by 88.01% to -$29.2 million in 2023, then plunged by 65.6% to -$48.4 million in 2024, then tumbled by 33.62% to -$64.7 million in 2025, then sank by 37.06% to -$88.6 million in 2026.
• The last three Profit After Tax figures came in at -$88.6 million (Q1 2026), -$64.7 million (Q4 2025), and -$69.4 million (Q3 2025), per Business Quant data.